XML 55 R41.htm IDEA: XBRL DOCUMENT v3.19.2
Segment and Related Information (Tables)
12 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense The Company evaluates segment performance based on income (loss) before interest income and other income and expense.

 

 

Diagnostics

 

 

Other

 

 

Total

 

Year ended June 30, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

789.4

 

 

$

61.7

 

 

$

851.1

 

Depreciation and amortization

 

 

67.7

 

 

 

5.3

 

 

 

73.0

 

Segment operating income (loss)

 

 

133.3

 

 

 

(125.7

)

 

 

7.6

 

Year ended June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

690.4

 

 

$

53.3

 

 

$

743.7

 

Depreciation and amortization

 

 

49.2

 

 

 

5.2

 

 

 

54.4

 

Segment operating income (loss)

 

 

142.6

 

 

 

(20.7

)

 

 

121.9

 

Year ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

679.4

 

 

$

49.3

 

 

$

728.7

 

Depreciation and amortization

 

 

42.8

 

 

 

5.5

 

 

 

48.3

 

Segment operating income (loss)

 

 

124.7

 

 

 

(80.7

)

 

 

44.0

 

 

 

 

Years Ended June 30,

 

 

 

2019

 

 

2018

 

 

2017

 

Total operating income for reportable segments

 

$

7.6

 

 

$

121.9

 

 

$

44.0

 

Unallocated amounts:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

3.2

 

 

 

1.8

 

 

 

1.2

 

Interest Expense

 

 

(12.0

)

 

 

(3.2

)

 

 

(6.0

)

Other

 

 

1.2

 

 

 

(0.4

)

 

 

(3.0

)

Income from operations before income taxes

 

 

0.0

 

 

 

120.1

 

 

 

36.2

 

Income tax provision

 

 

(4.4

)

 

 

(13.0

)

 

 

19.0

 

Net income

 

 

4.4

 

 

 

133.1

 

 

 

17.2

 

Net loss attributable to non-controlling interest

 

 

(0.2

)

 

 

(0.2

)

 

 

(0.2

)

Net income attributable to Myriad Genetics, Inc.

   stockholders

 

$

4.6

 

 

$

133.3

 

 

$

17.4

 

Schedule Of Comparison of Balance Sheet Assets by Operating Segment

The following table sets forth a comparison of balance sheet assets by operating segment:

 

 

 

June 30,

 

 

 

2019

 

 

2018

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

Diagnostics

 

 

25.7

 

 

 

12.2

 

Other

 

 

31.6

 

 

 

31.0

 

Total

 

$

57.3

 

 

$

43.2

 

Total Assets:

 

 

 

 

 

 

 

 

Diagnostics

 

 

1,215.6

 

 

 

841.5

 

Other

 

 

155.3

 

 

 

122.5

 

Total

 

$

1,370.9

 

 

$

964.0

 

Summary of Assets by Geographical Region

The following table reconciles assets by geographical region:

 

 

 

June 30,

 

 

 

2019

 

 

2018

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

United States

 

 

36.0

 

 

 

20.0

 

Rest of world

 

 

21.3

 

 

 

23.2

 

Total

 

$

57.3

 

 

$

43.2

 

Total Assets:

 

 

 

 

 

 

 

 

United States

 

 

1,265.8

 

 

 

853.4

 

Rest of world

 

 

105.1

 

 

 

110.6

 

Total

 

$

1,370.9

 

 

$

964.0

 

Reconciliation of Assets by Operating Segment and Geographic Region to Total Assets

The following table reconciles assets by operating segment and geographic region to total assets:

 

 

 

June 30,

 

 

 

2019

 

 

2018

 

Total assets by segment and geographical region

 

$

1,370.9

 

 

$

964.0

 

Cash, cash equivalents, and marketable investment

   securities (1)

 

 

191.8

 

 

 

211.3

 

Total

 

$

1,562.7

 

 

$

1,175.3

 

 

(1)

The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments